Leukocyte Recruitment in Hepatic Injury: Selectin-mediated Leukocyte Rolling is a Prerequisite for CD18-dependent Firm Adhesion
Overview
Affiliations
Background/aims: This study was designed to examine the role of selectins and CD18 in leukocyte recruitment in hepatic injury induced by tumor necrosis factor-alpha (TNF-alpha) and galactosamine (Gal) in vivo.
Methods: Intravital fluorescence microscopy of the hepatic microcirculation was used to quantify leukocyte-endothelium interactions provoked by 24 h of systemic TNF-alpha/Gal challenge in rats. Hepatic injury was evaluated with liver enzymes.
Results: When administered after 24 h of TNF-alpha/Gal challenge, fucoidan, a selectin-function inhibitor, reduced leukocyte rolling by 69%, whereas firm adhesion was unaltered. In contrast, passive immunization against CD18 decreased leukocyte adhesion by 60%, whereas rolling remained unchanged. Notably, when administered prior to TNF-alpha/Gal, fucoidan attenuated both leukocyte rolling and adhesion, by 57 and 69%, respectively. Pretreatment with an anti-CD18 antibody decreased TNF-alpha/Gal-induced rolling and firm adhesion by 25 and 90%, respectively. Moreover, pretreatment with fucoidan and the anti-CD18 antibody both protected against TNF-alpha/Gal-induced increases in liver enzymes. For example, the pretreatments reduced alanine aminotransferase by 59 and 87%, respectively.
Conclusions: Our data suggest that TNF-alpha/Gal-induced leukocyte rolling is selectin-mediated and a precondition for CD18-dependent firm adhesion in hepatic venules. Thus, reducing leukocyte recruitment by inhibition of selectins or CD18 may be useful to control TNF-alpha-induced liver injury.
The Many Roles of Cell Adhesion Molecules in Hepatic Fibrosis.
Hintermann E, Christen U Cells. 2019; 8(12).
PMID: 31771248 PMC: 6952767. DOI: 10.3390/cells8121503.
CD18 deficiency improves liver injury in the MCD model of steatohepatitis.
Pierce A, Duwaerts C, Siao K, Mattis A, Goodsell A, Baron J PLoS One. 2017; 12(9):e0183912.
PMID: 28873429 PMC: 5584926. DOI: 10.1371/journal.pone.0183912.
Tanaka M, Tanaka K, Masaki Y, Miyazaki M, Kato M, Kotoh K Int J Mol Med. 2013; 33(2):254-62.
PMID: 24317376 PMC: 3896462. DOI: 10.3892/ijmm.2013.1573.
Roller J, Wang Y, Rahman M, Schramm R, Laschke M, Menger M Inflamm Res. 2012; 62(3):275-82.
PMID: 23178793 DOI: 10.1007/s00011-012-0575-y.
2,3,7,8-TCDD enhances the sensitivity of mice to concanavalin A immune-mediated liver injury.
Fullerton A, Roth R, Ganey P Toxicol Appl Pharmacol. 2012; 266(2):317-27.
PMID: 23164664 PMC: 3535831. DOI: 10.1016/j.taap.2012.11.009.